Medical Device and Diagnostics is part of our work in Life Sciences.
Finnegan works with innovative clients of all sizes, including Fortune 100, Global 1000, and startups in the medical device and diagnostics industries. Saving lives, enhancing patients’ quality of life, improving healthcare delivery, and creating less-invasive ways to treat diseases are top priorities for the medical device industry. The competitive diagnostics industry seeks to improve testing with faster and more accurate results, as well as to develop new methods to detect evolving targets. Innovators face numerous challenges, including a highly litigious patent environment, tight profit margins, short product lifecycles, reimbursement programs that can affect product viability, and costly research and development activities that often require lengthy clinical trials. In addition, new devices must comply with the U.S. Food and Drug Administration’s safety and marketing regulations, which may require public disclosure of sensitive design information—all before the device is brought to market. To remain competitive, companies must protect and enforce their intellectual property rights.
At Finnegan, we have the legal experience and technical expertise to help clients address the many issues that arise in developing, protecting, and commercializing medical device and diagnostic inventions. Our experience ranges from working with in-house legal counsel at large companies on prosecution, due diligence, licensing, and high-stakes litigation, to advising senior management of startup companies on strategic business decisions to help get the company off the ground. We understand the highly competitive nature of the medical device industry, the demands of investors and shareholders to generate value, and the importance of securing early and strong protection of IP rights. We also help clients navigate the complex and evolving patent laws that bring challenges to protecting diagnostic inventions.
From determining the competitive landscape for new products to developing winning litigation strategies, we help by:
We work with medical device clients across a broad range of disciplines and technology, including:
We work with diagnostics clients across a broad range of disciplines and technology, including:
Finnegan represents BrainCo, a developer of brain-machine interface (BMI) wearables that combine electroencephalography (EEG) signal processing with artificial intelligence (AI) and machine learning (ML) to enable users to control electronic devices using brain signals. The firm works with BrainCo to develop and implement its intellectual property strategy, including drafting and prosecuting utility and design patent applications, in support of the company’s efforts to build a robust patent portfolio covering innovations and designs related to BMI technologies used in toys, smart home appliances, and robotic devices.
Successfully represented Bausch & Lomb and Eye Therapies in a Hatch-Waxman patent infringement litigation and parallel PTAB challenges concerning an ANDA for generic versions of over-the-counter Lumify® ocular drops. The cases settled favorably for our clients.
3:21-cv-16766, D.N.J., Judges Kirsch, Singh
IPR2022-00146, PTAB, Judges Hulse, New, Pollock
IPR2024-00467, PTAB, Judges Flax, Pollock, Yang
IPR2022-00142, PTAB, Judges Flax, Hulse, New, Pollock
1:23-cv-00756, D. Del., Judge Hall
IPR2024-00275, -00276, -00277, -00278, -00279, -00280, -00282, -00669, PTAB
1:21-cv-01610, D. Del., Judges Andrews, Hall
Represented Intuitive Surgical Operations on appeals from petitions for inter partes review (IPR) filed by Auris Health, Inc.
21-1473, -1732, -1733, Fed. Cir., Judges Prost, Dyk, Reyna
IPR2019-01173, -01533, -01547, PTAB, Judges Franklin, Hulse, Jenks, Worth, Yang
2:21-cv-06613, E.D.N.Y., Judge Reyes
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Articles
Prosecution History Estoppel: Navigating Limits on Equivalents in Patent Litigation
March/April 2026
Press Release
London-Based Life Sciences Litigator Jin Ooi Bolsters Finnegan’s Global IP Litigation Capabilities
June 8, 2026
Award/Ranking
Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award
May 13, 2026
Announcement
Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International
May 4, 2026
Commentary
Heartflow Accuses Rival of Building Competing AI Heart Tech on Stolen Secrets
April 23, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.